Wellington Management Group LLP increased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 8.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,549 shares of the medical equipment provider’s stock after buying an additional 2,396 shares during the period. Wellington Management Group LLP’s holdings in Zimmer Biomet Holdings were worth $3,731,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Parkside Financial Bank & Trust increased its stake in Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock worth $102,000 after buying an additional 22 shares in the last quarter. Sandy Spring Bank boosted its position in shares of Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after buying an additional 20 shares during the last quarter. Ledyard National Bank boosted its position in shares of Zimmer Biomet Holdings by 9.3% in the first quarter. Ledyard National Bank now owns 1,293 shares of the medical equipment provider’s stock worth $157,000 after buying an additional 110 shares during the last quarter. Penserra Capital Management LLC boosted its position in shares of Zimmer Biomet Holdings by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the medical equipment provider’s stock worth $157,000 after buying an additional 112 shares during the last quarter. Finally, YorkBridge Wealth Partners LLC boosted its position in shares of Zimmer Biomet Holdings by 7.1% in the first quarter. YorkBridge Wealth Partners LLC now owns 1,442 shares of the medical equipment provider’s stock worth $174,000 after buying an additional 95 shares during the last quarter. 83.62% of the stock is owned by institutional investors.

Shares of Zimmer Biomet Holdings, Inc. (ZBH) traded down 0.63% during mid-day trading on Monday, hitting $117.19. 807,533 shares of the stock were exchanged. Zimmer Biomet Holdings, Inc. has a 52-week low of $95.63 and a 52-week high of $133.49. The stock’s 50-day moving average price is $127.65 and its 200-day moving average price is $121.39. The company has a market cap of $23.65 billion, a P/E ratio of 33.38 and a beta of 1.20.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.10 by $0.02. The company had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The company’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.02 EPS. Equities research analysts anticipate that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, June 23rd were paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date of this dividend was Wednesday, June 21st. Zimmer Biomet Holdings’s payout ratio is 27.59%.

ILLEGAL ACTIVITY WARNING: “Zimmer Biomet Holdings, Inc. (ZBH) Shares Bought by Wellington Management Group LLP” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2017/08/07/zimmer-biomet-holdings-inc-zbh-shares-bought-by-wellington-management-group-llp-updated-updated-updated.html.

A number of brokerages recently commented on ZBH. Zacks Investment Research cut shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. BidaskClub cut shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. BMO Capital Markets boosted their price objective on shares of Zimmer Biomet Holdings from $136.00 to $140.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Leerink Swann boosted their price objective on shares of Zimmer Biomet Holdings from $141.00 to $146.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $137.00 price objective on shares of Zimmer Biomet Holdings and gave the company a “buy” rating in a research report on Friday, July 28th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $137.76.

In other news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Sang Yi sold 17,731 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $124.56, for a total value of $2,208,573.36. The disclosure for this sale can be found here. 1.07% of the stock is currently owned by company insiders.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related stocks with our FREE daily email newsletter.